ASML Slips as AI Funding Doubts Meet Chinese Memory Ambitions

ASML drops up to 3.3% on AI funding worries and CXMT memory progress, one day before Q3 2026 results; guidance is EUR 11-12bn revenue.

ASML shares are nursing losses of as much as 3.3% today, caught in a broader semiconductor selloff that has little to do with the Dutch equipment maker's own order book. What's rattling investors is a pair of industry-level worries: whether the capital is actually there to pay for the AI buildout, and how quickly Chinese memory makers are closing the gap.

The stock's decline lands the day before ASML reports third-quarter 2026 results, with the release scheduled for October 14 before the Amsterdam market opens and an investor call set for 15:00 CET. That timing turns a sector-wide mood swing into an immediate, company-specific test.

Funding, Not Technology, Becomes the Sticking Point

The loudest warning came from Broadcom CEO Hock Tan, who according to Reuters described capital as the single biggest constraint on AI development and likened some investment flows to gambling in a casino. Intel's chief executive struck a similar note a day earlier, flagging that available capital and financing costs could cap AI growth. The International Monetary Fund added its own voice today, pointing to potential global fallout from a correction in the AI market.

None of that speaks directly to ASML's numbers. It does, however, sharpen the question of how durable the spending commitments underpinning semiconductor demand really are. Enthusiasm for AI is not the same thing as a funded order, and the market is now pricing that distinction more critically.

A separate jolt came from Applied Materials, which reportedly skipped an industry spending forecast at its investor day. That left investors without a reference point for the pace of chip fab investment, and equipment suppliers including ASML slid alongside it. A missing forecast is not a confirmed deterioration in ASML's order book — but it removes a marker investors had been leaning on, and that vacuum appears to have fed today's selling.

CXMT Progress Adds a Second Front

Reuters also pointed to advances at Chinese memory chipmaker ChangXin Memory Technologies. CXMT says it has made progress on a new DRAM architecture and intends to launch a server memory product by the end of 2026. Mass production has not been demonstrated, so the announcement is not proof of a manufacturing breakthrough. Still, it intensifies the conversation about Chinese competition in memory — and technical announcements and realized fab investments are two very different signals when it comes to reading ASML's outlook.

Capacity Targets Take On Added Weight

With ASML no longer publishing quarterly order figures, production targets have become the main window into expected demand and available delivery capacity. That makes concrete expansion statements more valuable than ever.

In July, the company said it would lift annual Low-NA EUV capacity by 30% to 85 machines in 2027, a figure it describes as already nearly fully booked. Analysts are looking further. UBS sees room for capacity increases beyond what has been announced, while Morgan Stanley models more than 90 shipments for 2027 — though capacity and actual deliveries remain distinct measures.

For 2028, ASML is weighing a further expansion to roughly 110 machines a year, with no decision yet made. Substantial orders already in hand support those deliberations but do not constitute a binding commitment to additional capacity.

The lead times involved are substantial. A single Low-NA EUV machine costs around EUR 200 million and takes more than a year from order to delivery. ASML aims to cut manufacturing and testing time by roughly a third — a reminder that execution depends not only on customer budgets but on the company's own production throughput.

Margins and Guidance Must Line Up

For the third quarter of 2026, ASML has guided to revenue of EUR 11–12 billion and a gross margin of 55–57%, putting the focus on growth paired with improved profitability. CFO Roger Dassen said in July that higher EUV productivity opens up additional pricing headroom.

That sets a clear bar for tomorrow's report: demand, delivery capability and margins all need to hold together. The announced expansion on its own does not dispel today's financing concerns.

The Analyst Counterweight

Against the gloom, Bank of America raised its ASML price target from EUR 2,452 to EUR 2,557 just over a week ago and kept its buy rating, according to media reports. That stance reflects confidence in what has yet to be delivered rather than results already on the books.

The two layers are worth keeping apart. Funding worries and Chinese competition explain the pressured backdrop. Whether that skepticism actually reaches ASML's business is a question the quarterly figures and management commentary must answer — not the share price alone. Today's selloff argues for more caution toward far-reaching investment expectations. It does not yet justify a blanket verdict on ASML.